Mountain Pacific Investment Advisers’s Merck MRK Stock Holding History

Mountain Pacific Investment Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$438K	Hold	3,641	–	–	0.08%	109
2025 Q4	$383K	Hold	3,641	–	–	0.06%	118
2025 Q3	$306K	Hold	3,641	–	–	0.05%	127
2025 Q2	$288K	Hold	3,641	–	–	0.02%	130
2025 Q1	$327K	Sell	3,641 -900	-20%	-$84K	0.02%	126
2024 Q4	$452K	Hold	4,541	–	–	0.03%	109
2024 Q3	$516K	Buy	4,541 +96	+2%	+$11.4K	0.04%	108
2024 Q2	$550K	Hold	4,445	–	–	0.04%	103
2024 Q1	$587K	Sell	4,445 -300	-6%	-$37K	0.03%	105
2023 Q4	$517K	Hold	4,745	–	–	0.03%	106
2023 Q3	$488K	Buy	4,745 +869	+22%	+$93.7K	0.03%	102
2023 Q2	$447K	Sell	3,876 -250	-6%	-$28.4K	0.03%	109
2023 Q1	$439K	Sell	4,126 -1,174	-22%	-$127K	0.03%	108
2022 Q4	$588K	Hold	5,300	–	–	0.04%	94
2022 Q3	$456K	Hold	5,300	–	–	0.04%	99
2022 Q2	$483K	Hold	5,300	–	–	0.04%	100
2022 Q1	$435K	Buy	5,300 +115	+2%	+$9.07K	0.03%	113
2021 Q4	$397K	Sell	5,185 -300	-5%	-$23.9K	0.02%	116
2021 Q3	$412K	Buy	5,485 +11	+0.2%	+$837	0.03%	111
2021 Q2	$426K	Sell	5,474 -263	-5%	-$19.6K	0.03%	110
2021 Q1	$422K	Buy	5,737 +315	+6%	+$23.2K	0.03%	110
2020 Q4	$423K	Hold	5,422	–	–	0.03%	104
2020 Q3	$429K	Buy	5,422 +419	+8%	+$32.8K	0.04%	96
2020 Q2	$369K	Sell	5,003 -733	-13%	-$55.2K	0.03%	102
2020 Q1	$421K	Buy	5,736 +628	+12%	+$49.4K	0.04%	91
2019 Q4	$443K	Buy	5,108 +105	+2%	+$8.62K	0.04%	99
2019 Q3	$402K	Hold	5,003	–	–	0.04%	100
2019 Q2	$400K	Hold	5,003	–	–	0.04%	96
2019 Q1	$397K	Hold	5,003	–	–	0.04%	93
2018 Q4	$365K	Hold	5,003	–	–	0.04%	89
2018 Q3	$339K	Hold	5,003	–	–	0.03%	100
2018 Q2	$290K	Hold	5,003	–	–	0.03%	104
2018 Q1	$260K	Sell	5,003 -317	-6%	-$17.1K	0.03%	103
2017 Q4	$286K	Sell	5,320 -1,676	-24%	-$92.9K	0.03%	98
2017 Q3	$427K	Hold	6,996	–	–	0.05%	87
2017 Q2	$428K	Buy	6,996 +419	+6%	+$25.5K	0.05%	87
2017 Q1	$399K	Hold	6,577	–	–	0.05%	85
2016 Q4	$369K	Hold	6,577	–	–	0.04%	85
2016 Q3	$392K	Hold	6,577	–	–	0.04%	86
2016 Q2	$362K	Hold	6,577	–	–	0.04%	86
2016 Q1	$332K	Hold	6,577	–	–	0.04%	86
2015 Q4	$331K	Buy	6,577 +209	+3%	+$10.5K	0.04%	86
2015 Q3	$300K	Hold	6,368	–	–	0.04%	89
2015 Q2	$346K	Buy	6,368 +944	+17%	+$52.9K	0.04%	86
2015 Q1	$298K	Buy	5,424 +316	+6%	+$17.9K	0.03%	90
2014 Q4	$277K	Buy	5,108 +1,440	+39%	+$80.2K	0.03%	94
2014 Q3	$207K	Buy	+3,668	New	+$206K	0.03%	101

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mountain Pacific Investment Advisers's MRK Position: Q1 2026 in Review

Mountain Pacific Investment Advisers held its Merck (MRK) position steady in Q1 2026 at 3,641 shares worth $438K. The position accounts for 0.08% of the portfolio, ranked #109.

Mountain Pacific Investment Advisers first reported a position in MRK in Q3 2014 and has held it in 47 quarters since. The position peaked at $588K in Q4 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Mountain Pacific Investment Advisers held 3,641 shares of Merck worth $438K as of Q1 2026.
Mountain Pacific Investment Advisers left its Merck share count unchanged in Q1 2026.
Merck made up 0.08% of Mountain Pacific Investment Advisers's portfolio in Q1 2026, its #109 holding.
Mountain Pacific Investment Advisers first reported a position in Merck in Q3 2014 and has held it in 47 quarters since.
Mountain Pacific Investment Advisers's Merck position peaked at $588K in Q4 2022.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mountain Pacific Investment Advisers's 13F filing for Q1 2026, filed 16 Apr 2026.